Cargando…
Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review
Rationale: Physiologically based pharmacokinetic (PBPK) and population pharmacokinetic (PK) modelling approaches are widely accepted in non-radiopharmaceutical drug development and research, while there is no major role for these approaches in radiopharmaceutical development yet. In this review, a l...
Autores principales: | Siebinga, Hinke, de Wit-van der Veen, Berlinda J., Stokkel, Marcel D.M., Huitema, Alwin D.R., Hendrikx, Jeroen J.M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706588/ https://www.ncbi.nlm.nih.gov/pubmed/36451855 http://dx.doi.org/10.7150/thno.77279 |
Ejemplares similares
-
Predicting the effect of different folate doses on [(68)Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling
por: Siebinga, Hinke, et al.
Publicado: (2023) -
Predicting [(177)Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [(68)Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
por: Siebinga, Hinke, et al.
Publicado: (2023) -
A physiologically based pharmacokinetic model for [(68)Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients
por: Siebinga, Hinke, et al.
Publicado: (2023) -
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of
(177)Lu‐PSMA‐617 in prostate cancer patients
por: Siebinga, Hinke, et al.
Publicado: (2023) -
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of (68)Ga-DOTATATE in patients without neuroendocrine tumors
por: Siebinga, H., et al.
Publicado: (2021)